Topics

Lineage Cell Therapeutics Receives US Patent for Immunogenic Dendritic Cells Generating System

11:27 EDT 26 Aug 2019 | Investing News Network

Lineage Cell Therapeutics (NYSE American:LCTX, TASE:LCTX) has announced that the US Patent and Trademark Office (USPTO) has issued US Patent No. 10,344,262 for a system to produce antigen presenting dendritic cells from human embryonic stem cells (hESCs). As quoted in the press release: The claimed system and cell populations involve culturing cells in a serum-free … Continued

The post Lineage Cell Therapeutics Receives US Patent for Immunogenic Dendritic Cells Generating System appeared first on Investing News Network.

Original Article: Lineage Cell Therapeutics Receives US Patent for Immunogenic Dendritic Cells Generating System

NEXT ARTICLE

More From BioPortfolio on "Lineage Cell Therapeutics Receives US Patent for Immunogenic Dendritic Cells Generating System"

Quick Search

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...